Nuvectis Initiates Phase 1b Lung Cancer Drug Trial

source:

[1] Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC (https://finance.yahoo.com/news/nuvectis-pharm ...)

Nuvectis Initiates Phase 1b Lung Cancer Drug Trial

Related News

BlackSky Stock Gains 80% as Gen-3 Satellite Goes Live

Google's Dual AI Strategy Wins as OpenAI User Growth Stalls

China's $1.076T Trade Surplus Fuels Yuan Appreciation Bets